4//SEC Filing
Ordentlich Peter 4
Accession 0001562180-23-000950
CIK 0001395937other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:59 PM ET
Size
8.7 KB
Accession
0001562180-23-000950
Insider Transaction Report
Form 4
Ordentlich Peter
Chief Technology Officer
Transactions
- Sale
Common Stock
2023-02-01$28.43/sh−69$1,962→ 0 total - Other
Common Stock
2023-01-31$17.32/sh+69$1,195→ 69 total - Award
Stock Options (Right to buy)
2023-02-02$28.55/sh+90,000$2,569,500→ 90,000 totalExercise: $28.55Exp: 2033-02-02→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 69 shares by the Reporting Person on 01/31/2023 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]1/48th of the shares subject to the option shall vest monthly over a four-year period.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001594274
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:59 PM ET
- Size
- 8.7 KB